Sherrington Pharmaceuticals Overview

  • Year Founded
  • 2009

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $1.69M

Sherrington Pharmaceuticals General Information

Description

Developer of a pain treatment drug. The company develops chronic and refractory pain treatment for end-stage cancer patients and other severe pain indications.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 1251 Avenue Of The Americas
  • Floor 20
  • New York, NY 10020
  • United States
+1 (212)
Primary Industry
Pharmaceuticals
Vertical(s)
Corporate Office
  • 1251 Avenue Of The Americas
  • Floor 20
  • New York, NY 10020
  • United States
+1 (212)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Sherrington Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 09-Oct-2013 $1.69M Completed Generating Revenue
2. Grant 01-Jan-2010 Completed Startup
1. Early Stage VC Completed Startup
To view Sherrington Pharmaceuticals’s complete valuation and funding history, request access »

Sherrington Pharmaceuticals Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Aceras BioMedical Venture Capital Minority
To view Sherrington Pharmaceuticals’s complete investors history, request access »

Sherrington Pharmaceuticals FAQs

  • When was Sherrington Pharmaceuticals founded?

    Sherrington Pharmaceuticals was founded in 2009.

  • Where is Sherrington Pharmaceuticals headquartered?

    Sherrington Pharmaceuticals is headquartered in New York, NY.

  • What industry is Sherrington Pharmaceuticals in?

    Sherrington Pharmaceuticals’s primary industry is Pharmaceuticals.

  • Is Sherrington Pharmaceuticals a private or public company?

    Sherrington Pharmaceuticals is a Private company.

  • What is the current valuation of Sherrington Pharmaceuticals?

    The current valuation of Sherrington Pharmaceuticals is .

  • What is Sherrington Pharmaceuticals’s current revenue?

    The current revenue for Sherrington Pharmaceuticals is .

  • Who are Sherrington Pharmaceuticals’s investors?

    Aceras BioMedical has invested in Sherrington Pharmaceuticals.

  • When was Sherrington Pharmaceuticals acquired?

    Sherrington Pharmaceuticals was acquired on 09-Oct-2013.

  • Who acquired Sherrington Pharmaceuticals?

    Sherrington Pharmaceuticals was acquired by Sorrento Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process